|
1
|
Skvarc DR, Berk M, Byrne LK, Dean OM, Dodd
S, Lewis M, Marriott A, Moore EM, Morris G, Page RS and Gray L:
Post-operative cognitive dysfunction: An exploration of the
inflammatory hypothesis and novel therapies. Neurosci Biobehav Rev.
84:116–133. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jevtovic-Todorovic V, Absalom AR, Blomgren
K, Brambrink A, Crosby G, Culley DJ, Fiskum G, Giffard RG, Herold
KF, Loepke AW, et al: Anaesthetic neurotoxicity and
neuroplasticity: An expert group report and statement based on the
BJA Salzburg Seminar. Br J Anaesth. 111:143–151. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Callaway JK, Jones NC, Royse AG and Royse
CF: Memory impairment in rats after desflurane anesthesia is age
and dose dependent. J Alzheimers Dis. 44:995–1005. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Shen X, Dong Y, Xu Z, Wang H, Miao C,
Soriano SG, Sun D, Baxter MG, Zhang Y and Xie Z: Selective
anesthesia-induced neuroinflammation in developing mouse brain and
cognitive impairment. Anesthesiology. 118:502–515. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Feng X, Degos V, Koch LG, Britton SL, Zhu
Y, Vacas S, Terrando N, Nelson J, Su X and Maze M: Surgery results
in exaggerated and persistent cognitive decline in a rat model of
the metabolic syndrome. Anesthesiology. 118:1098–1105. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yang C, Zhu B, Ding J and Wang ZG:
Isoflurane anesthesia aggravates cognitive impairment in
streptozotocin-induced diabetic rats. Int J Clin Exp Med.
7:903–910. 2014.PubMed/NCBI
|
|
7
|
Yue T, Shanbin G, Ling M, Yuan W, Ying X
and Ping Z: Sevoflurane aggregates cognitive dysfunction and
hippocampal oxidative stress induced by β-amyloid in rats. Life
Sci. 143:194–201. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wadhwa M, Prabhakar A, Ray K, Roy K,
Kumari P, Jha PK, Kishore K, Kumar S and Panjwani U: Inhibiting the
microglia activation improves the spatial memory and adult
neurogenesis in rat hippocampus during 48 h of sleep deprivation. J
Neuroinflammation. 14:2222017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li Z, Ni C, Xia C, Jaw J, Wang Y, Cao Y,
Xu M and Guo X: Calcineurin/nuclear factor-κB signaling mediates
isoflurane-induced hippocampal neuroinflammation and subsequent
cognitive impairment in aged rats. Mol Med Rep. 15:201–209. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cai JC, Liu W, Lu F, Kong WB, Zhou XX,
Miao P, Lei CX and Wang Y: Resveratrol attenuates neurological
deficit and neuroinflammation following intracerebral hemorrhage.
Exp Ther Med. 15:4131–4138. 2018.PubMed/NCBI
|
|
11
|
Block ML: Neuroinflammation: Modulating
mighty microglia. Nat Chem Biol. 10:988–989. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu H, Huang F, Wu H, Zhang B, Shi H, Wu X
and Hu Z: Isoastragaloside I inhibits NF-κB activation and
inflammatory responses in BV-2 microglial cells stimulated with
lipopolysaccharide. Int J Mol Med. 40:1270–1276. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jin M, Park SY, Shen Q, Lai Y, Ou X, Mao
Z, Lin D, Yu Y and Zhang W: Anti-neuroinflammatory effect of
curcumin on Pam3CSK4-stimulated microglial cells. Int J Mol Med.
41:521–530. 2018.PubMed/NCBI
|
|
14
|
Zhang Z, Yuan H, Zhao H, Qi B, Li F and An
L: PPARγ activation ameliorates postoperative cognitive decline
probably through suppressing hippocampal neuroinflammation in aged
mice. Int Immunopharmacol. 43:53–61. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gagnon K, Baril AA, Gagnon JF, Fortin M,
Décary A, Lafond C, Desautels A, Montplaisir J and Gosselin N:
Cognitive impairment in obstructive sleep apnea. Pathol Biol
(Paris). 62:233–240. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jin F, Liu J and Zhang X, Cai W, Zhang Y,
Zhang W, Yang J, Lu G and Zhang X: Effect of continuous positive
airway pressure therapy on inflammatory cytokines and
atherosclerosis in patients with obstructive sleep apnea syndrome.
Mol Med Rep. 16:6334–6339. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sforza E and Roche F: Chronic intermittent
hypoxia and obstructive sleep apnea: An experimental and clinical
approach. Hypoxia (Auckl). 4:99–108. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yaffe K, Laffan AM, Harrison SL, Redline
S, Spira AP, Ensrud KE, Ancoli-Israel S and Stone KL:
Sleep-disordered breathing, hypoxia, and risk of mild cognitive
impairment and dementia in older women. JAMA. 306:613–619. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Moore-Carrasco R, Poblete Bustamante M,
González Guerra O, Leiva Madariaga E, Mujica Escudero V, Aranguez
Arellano C and Palomo I: Peroxisome proliferator-activated
receptors: Targets for the treatment of metabolic illnesses
(Review). Mol Med Rep. 1:317–324. 2008.PubMed/NCBI
|
|
20
|
Martin H: Role of PPAR-gamma in
inflammation. Prospects for therapeutic intervention by food
components. Mutat Res. 690:57–63. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang T, Shao B and Liu GA: Rosuvastatin
promotes the differentiation of peripheral blood monocytes into M2
macrophages in patients with atherosclerosis by activating PPAR-γ.
Eur Rev Med Pharmacol Sci. 21:4464–4471. 2017.PubMed/NCBI
|
|
22
|
Wang Q, Su YY, Li YQ, Zhang YF, Yang S,
Wang JL and Li HY: Atorvastatin alleviates renal
ischemia-reperfusion injury in rats by promoting M1-M2 transition.
Mol Med Rep. 15:798–804. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Culman J, Zhao Y, Gohlke P and Herdegen T:
PPAR-gamma: Therapeutic target for ischemic stroke. Trends
Pharmacol Sci. 28:244–249. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kapadia R, Yi JH and Vemuganti R:
Mechanisms of anti-inflammatory and neuroprotective actions of
PPAR-gamma agonists. Front Biosci. 13:1813–1826. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Nicolakakis N and Hamel E: The nuclear
receptor PPARgamma as a therapeutic target for cerebrovascular and
brain dysfunction in Alzheimer's disease. Front Aging Neurosci.
2:212010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Domi E, Uhrig S, Soverchia L, Spanagel R,
Hansson AC, Barbier E, Heilig M, Ciccocioppo R and Ubaldi M:
Genetic deletion of neuronal PPARγ enhances the emotional response
to acute stress and exacerbates anxiety: An effect reversed by
rescue of amygdala PPARγ Function. J Neurosci. 36:12611–12623.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bernardo A and Minghetti L: Regulation of
glial cell functions by PPAR-gamma natural and synthetic agonists.
PPAR Res. 2008:8641402008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Dong P, Zhao J, Li N, Lu L, Li L, Zhang X,
Yang B, Zhang L and Li D: Sevoflurane exaggerates cognitive decline
in a rat model of chronic intermittent hypoxia by aggravating
microglia-mediated neuroinflammation via downregulation of PPAR-γ
in the hippocampus. Behav Brain Res. 347:325–331. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Callaway JK, Jones NC, Royse AG and Royse
CF: Sevoflurane anesthesia does not impair acquisition learning or
memory in the Morris water maze in young adult and aged rats.
Anesthesiology. 117:1091–1101. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Li D, Liu L, Li L, Li X, Huang B, Zhou C,
Zhang Z, Wang C, Dong P, Zhang X, et al: Sevoflurane induces
exaggerated and persistent cognitive decline in a type II diabetic
rat model by aggregating hippocampal inflammation. Front Pharmacol.
8:8862017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Cippitelli A, Domi E, Ubaldi M, Douglas
JC, Li HW, Demopulos G, Gaitanaris G, Roberto M, Drew PD, Kane CJ
and Ciccocioppo R: Protection against alcohol-induced neuronal and
cognitive damage by the PPARγ receptor agonist pioglitazone. Brain
Behav Immun. 64:320–329. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhao Q, Wu X, Yan S, Xie X, Fan Y, Zhang
J, Peng C and You Z: The antidepressant-like effects of
pioglitazone in a chronic mild stress mouse model are associated
with PPARγ-mediated alteration of microglial activation phenotypes.
J Neuroinflammation. 13:2592016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Grommes C, Karlo JC, Caprariello A,
Blankenship D, Dechant A and Landreth GE: The PPARγ agonist
pioglitazone crosses the blood-brain barrier and reduces tumor
growth in a human xenograft model. Cancer Chemother Pharmacol.
71:929–936. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Garvey JF, Pengo MF, Drakatos P and Kent
BD: Epidemiological aspects of obstructive sleep apnea. J Thorac
Dis. 7:920–929. 2015.PubMed/NCBI
|
|
35
|
Liu M, Bachstetter AD, Cass WA, Lifshitz J
and Bing G: Pioglitazone attenuates neuroinflammation and promotes
dopaminergic neuronal survival in the nigrostriatal system of rats
after diffuse brain injury. J Neurotrauma. 34:414–422. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Collino M, Aragno M, Mastrocola R,
Gallicchio M, Rosa AC, Dianzani C, Danni O, Thiemermann C and
Fantozzi R: Modulation of the oxidative stress and inflammatory
response by PPAR-gamma agonists in the hippocampus of rats exposed
to cerebral ischemia/reperfusion. Eur J Pharmacol. 530:70–80. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Chen F, Wang M, O'Connor JP, He M,
Tripathi T and Harrison LE: Phosphorylation of PPARgamma via active
ERK1/2 leads to its physical association with p65 and inhibition of
NF-kappabeta. J Cell Biochem. 90:732–744. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ruan H, Pownall HJ and Lodish HF:
Troglitazone antagonizes tumor necrosis factor-alpha-induced
reprogramming of adipocyte gene expression by inhibiting the
transcriptional regulatory functions of NF-kappaB. J Biol Chem.
278:28181–28192. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wang W, Chen X, Zhang J, Zhao Y, Li S, Tan
L, Gao J, Fang X and Luo A: Glycyrrhizin attenuates
isoflurane-induced cognitive deficits in neonatal rats via its
anti-inflammatory activity. Neuroscience. 316:328–336. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zhang L, Zhang J, Yang L, Dong Y, Zhang Y
and Xie Z: Isoflurane and sevoflurane increase interleukin-6 levels
through the nuclear factor-kappa B pathway in neuroglioma cells. Br
J Anaesth. 110 (Suppl 1):i82–i91. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Warden A, Truitt J, Merriman M, Ponomareva
O, Jameson K, Ferguson LB, Mayfield RD and Harris RA: Localization
of PPAR isotypes in the adult mouse and human brain. Sci Rep.
6:276182016. View Article : Google Scholar : PubMed/NCBI
|
